MENU
CURE
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

CURE stock forecast, quote, news & analysis

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index... Show more

Category: #Trading
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for CURE with price predictions
Nov 10, 2026

Momentum Indicator for CURE turns positive, indicating new upward trend

CURE saw its Momentum Indicator move above the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In 86 of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CURE just turned positive on October 09, 2026. Looking at past instances where CURE's MACD turned positive, the stock continued to rise in 42 of 46 cases over the following month. The odds of a continued upward trend are 90%.

CURE moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CURE crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +6.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in 288 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 230 of 247 cases where CURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for CURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 30 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 59 of 67 cases where CURE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

CURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Health Care Select Sector Index. The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. It is non-diversified.

Market Cap

The average market capitalization across the Direxion Daily Healthcare Bull 3X ETF (CURE) ETF is 117.06B. The market cap for tickers in the group ranges from 9.59B to 1.21T. LLY holds the highest valuation in this group at 1.21T. The lowest valued company is HSIC at 9.59B.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily Healthcare Bull 3X ETF (CURE) ETF was 12%. For the same ETF, the average monthly price growth was 34%, and the average quarterly price growth was 407%. ALGN experienced the highest price growth at 15%, while ILMN experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Direxion Daily Healthcare Bull 3X ETF (CURE) ETF was -26%. For the same stocks of the ETF, the average monthly volume growth was -18% and the average quarterly volume growth was -19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 44
Price Growth Rating: 24
SMR Rating: 58
Profit Risk Rating: 65
Seasonality Score: 24 (-100 ... +100)
Momentum Indicator for CURE turns positive, indicating new upward trend